A Comparison of Two Drug Reimbursement Pricing Models: B.C. Pharmacare and the Ontario Drug Benefit Programme
AbstractBritish Columbia's Pharmacare and the Ontario Drug Benefit Programme are compared with respect to drug prices, the market share of generic and brand names, and the existence of a difference between the government reimbursement price and the cost of the drug to the pharmacist. The evidence suggests that the best available price system of Ontario yields lower interchangeable drug prices than the actual acquisition cost system of British Columbia.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoArticle provided by Canadian Economics Association in its journal Canadian Journal of Economics.
Volume (Year): 26 (1993)
Issue (Month): 4 (November)
Contact details of provider:
Postal: Canadian Economics Association Prof. Steven Ambler, Secretary-Treasurer c/o Olivier Lebert, CEA/CJE/CPP Office C.P. 35006, 1221 Fleury Est Montréal, Québec, Canada H2C 3K4
Web page: http://economics.ca/cje/
More information through EDIRC
You can help add them by filling out this form.
reading list or among the top items on IDEAS.Access and download statisticsgeneral information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Prof. Werner Antweiler).
If references are entirely missing, you can add them using this form.